SCHEMBL24534751

SCHEMBL24534751

C/C=C1\N=C(c2cccs2)OC1=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.71
KMT2A Q03164 5/20 0.51
MAPT P10636 4/20 0.51
ALDH1A1 P00352 3/20 0.51
POLB P06746 2/20 0.51
HPGD P15428 1/20 0.51
NPSR1 Q6W5P4 2/20 0.51
GAA P10253 1/20 0.51
MEN1 O00255 3/20 0.49
PLA2G1B P04054 1/20 0.49
BLM P54132 1/20 0.49
ATG4B Q9Y4P1 1/20 0.49
MAPK1 P28482 1/20 0.47
LMNA P02545 1/20 0.46
RECQL P46063 1/20 0.46
MCL1 Q07820 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NOTUM Q6P988 2/20 0.45
MASP2 O00187 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3503107 0.81 KMT2A (0.65) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL3503106 0.81 KMT2A (0.65) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL6873085 0.81 KMT2A (0.65) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL14511968 0.80 KDM4E (0.62) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL24241565 0.78 KDM4E (0.59) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL29518104 0.78 KDM4E (0.59) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL22505271 0.77 KDM4E (0.44) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL15512623 0.77 KMT2A (0.65) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL15512624 0.77 KMT2A (0.65) KDM4EKMT2AMAPTALDH1A1POLB
SCHEMBL16500473 0.77 KMT2A (0.65) KDM4EKMT2AMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT Yonsei University, University - Industry Foundation (UIF) (KR) 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT EPX, CFTR, MPO KDM4E 4043/4885KMT2A 3803/4885MAPT 2408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.